Palisade Bio, Inc. (PALI) has 20 known insider and institutional holders on record. The largest holder is GARR RICHARD with 1,336,121 shares. Other notable holders include REGAL ONE CORP and JOHE KARL.
Over the last 12 months, insiders have made 22 transactions in PALI stock — 18 buys (valued at $17.76K) and 2 sells (valued at $10.3K). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
PALI Insider Ownership
Top Holder
GARR RICHARD
1,336,121 shares
Buys (12 mo)
18
$17.76K value
Sells (12 mo)
2
$10.3K value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Garr Richard |
CEO |
1,336,121 |
2015-11-03 |
|
| 2 |
Regal One Corp |
10 Percent Owner |
1,293,911 |
2007-03-19 |
|
| 3 |
Johe Karl |
Chief Scientific Officer |
826,304 |
2015-11-16 |
|
| 4 |
Smith Sandford D |
Director |
219,916 |
2019-07-03 |
|
| 5 |
Oldaker William Clyde |
Director |
187,510 |
2019-07-03 |
|
| 6 |
Conron John |
Chief Financial Officer |
115,492 |
2011-02-03 |
|
| 7 |
Sohn Catherine A. |
Director |
106,952 |
2015-07-06 |
|
| 8 |
Daly Richard J |
Chief Executive Officer |
100,000 |
2017-11-09 |
|
| 9 |
Chuang Emil |
Director |
60,600 |
2025-11-06 |
|
| 10 |
Wei Binxian |
Director |
60,600 |
2025-11-06 |
|
| 11 |
Westreich Stanley |
Director |
59,660 |
2018-07-05 |
|
| 12 |
Hallam Thomas |
Chief Executive Officer |
40,000 |
2022-08-18 |
|
| 13 |
Finley John David |
CEO, CFO |
26,667 |
2026-02-13 |
|
| 14 |
Jones Mitchell Lawrence |
Chief Medical Officer |
15,252 |
2026-02-13 |
|
| 15 |
Dawson Michael John |
Chief Medical Officer |
15,000 |
2022-03-31 |
|
| 16 |
Williams Donald Allen |
Director |
10,728 |
2026-01-21 |
|
| 17 |
Ogilvie Scott Varde |
Director |
10,106 |
2019-10-11 |
|
| 18 |
Lloyd Jones Jonathan Brian |
Chief Financial Officer |
7,859 |
2017-03-27 |
|
| 19 |
Mazzo David J |
Director |
6,000 |
2021-04-26 |
|
| 20 |
Trenschel Robert J. |
Director |
5,820 |
2023-11-24 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-02-12 |
Jones Mitchell Lawrence |
Chief Medical Officer |
Informative Sell |
1,989 |
$1.75 |
$3.48K |
| 2026-02-11 |
Jones Mitchell Lawrence |
Chief Medical Officer |
Option Exercise |
8,000 |
- |
- |
| 2026-02-12 |
Finley John David |
CEO, CFO |
Informative Sell |
3,896 |
$1.75 |
$6.82K |
| 2026-02-11 |
Finley John David |
CEO, CFO |
Option Exercise (Sell) |
13,333 |
- |
- |
| 2026-02-09 |
Jones Mitchell Lawrence |
Chief Medical Officer |
RSU Award |
787,000 |
- |
- |
| 2026-02-09 |
Finley John David |
CEO, CFO |
RSU Award |
2,011,000 |
- |
- |
| 2026-01-16 |
Williams Donald Allen |
Director |
Informative Buy |
5,000 |
$1.67 |
$8.36K |
| 2026-01-09 |
Williams Donald Allen |
Director |
Informative Buy |
5,000 |
$1.88 |
$9.4K |
| 2025-10-06 |
Chuang Emil |
Director |
RSU Award |
60,600 |
- |
- |
| 2025-10-06 |
Wei Binxian |
Director |
RSU Award |
60,600 |
- |
- |
| 2025-10-06 |
Williams Donald Allen |
Director |
RSU Award |
182,000 |
- |
- |
| 2025-10-06 |
Jones Mitchell Lawrence |
Chief Medical Officer |
RSU Award |
7,665,800 |
- |
- |
| 2025-10-06 |
Chuang Emil |
Director |
RSU Award |
510,700 |
- |
- |
| 2025-10-06 |
Finley John David |
CEO, CFO |
RSU Award |
9,179,400 |
- |
- |
| 2025-10-06 |
Wei Binxian |
Director |
RSU Award |
510,700 |
- |
- |
| 2025-10-06 |
Williams Donald Allen |
Director |
RSU Award |
1,538,700 |
- |
- |
| 2025-09-04 |
Jones Mitchell Lawrence |
Chief Medical Officer |
RSU Award |
289,000 |
- |
- |
| 2025-09-04 |
Chuang Emil |
Director |
RSU Award |
18,800 |
- |
- |
| 2025-09-04 |
Finley John David |
CEO, CFO |
RSU Award |
323,400 |
- |
- |
| 2025-09-04 |
Wei Binxian |
Director |
RSU Award |
18,800 |
- |
- |
| 2025-09-04 |
Williams Donald Allen |
Director |
RSU Award |
64,400 |
- |
- |
| 2025-07-07 |
Chuang Emil |
Director |
Unknown |
- |
- |
- |